Hyperkalemia is one of the most fatal electrolyte abnor- malities; it is also the most treatable. American Heart Association defines hyperkalemia as greater than 5 mEq/L, and moderate (6 - 7 mEq/L) and severe (>7 mEq/L) are life threatening and require immediate therapy. Thera- peutic options aim to antagonize the effects of hyper- kalemia at the cellular level (calcium salts, decrease se- rum potassium levels by promoting the influx of potas- sium into cells of the body (insulin and sodium bicar- bonate), and finally, remove potassium from the body (resins, loop diuretics, hemodialysis)